- Home /
- Vaniqa (eflornithine hydrochloride) Cream, 13.9%
- Product Details
- How to use
- Ingredients
- Concerns
VANIQA is an FDA-approved prescription cream clinically proven to reduce the growth of unwanted facial hair in women. You may see results as early as
4-8 weeks when used twice a day, at least 8 hours apart, or as directed by your doctor. Individual results may vary.
You will need to continue your normal procedures for hair removal until desired results have been achieved.
VANIQA® statistically significantly reduced how bothered patients felt by their facial hair and by the time spent removing, treating, or concealing facial hair. These patient-observable differences were seen as early as 8 weeks after initiating treatment.
VANIQA® statistically significantly reduced how bothered patients felt by their facial hair and by the time spent removing, treating, or concealing facial hair. These patient-observable differences were seen as early as 8 weeks after initiating treatment.
Apply a thin layer of VANIQA® (eflornithine hydrochloride) cream, 13.9% to affected areas of the face and adjacent involved areas under the chin and rub in thoroughly. Do not wash treated area for at least 4 hours. Use twice daily at least 8 hours apart or as directed by a physician. The patient should continue to use hair removal techniques as needed in conjunction with VANIQA®. (VANIQA® should be applied at least 5 minutes after hair removal.) Cosmetics or sunscreens may be applied over treated areas after cream has dried.
Eflornithine hydrochloride cream, 13.9% (ceteareth-20; cetearyl alcohol; dimethicone; glyceryl stearate; methylparaben; mineral oil; PEG-100 stearate; phenoxyethanol; propylparaben; stearyl alcohol; and water.
VANIQA® (eflornithine hydrochloride) cream, 13.9% is indicated for the reduction of unwanted facial hair in women.
Product Details
VANIQA is an FDA-approved prescription cream clinically proven to reduce the growth of unwanted facial hair in women. You may see results as early as
4-8 weeks when used twice a day, at least 8 hours apart, or as directed by your doctor. Individual results may vary.
You will need to continue your normal procedures for hair removal until desired results have been achieved.
VANIQA® statistically significantly reduced how bothered patients felt by their facial hair and by the time spent removing, treating, or concealing facial hair. These patient-observable differences were seen as early as 8 weeks after initiating treatment.
VANIQA® statistically significantly reduced how bothered patients felt by their facial hair and by the time spent removing, treating, or concealing facial hair. These patient-observable differences were seen as early as 8 weeks after initiating treatment.
How to use
Apply a thin layer of VANIQA® (eflornithine hydrochloride) cream, 13.9% to affected areas of the face and adjacent involved areas under the chin and rub in thoroughly. Do not wash treated area for at least 4 hours. Use twice daily at least 8 hours apart or as directed by a physician. The patient should continue to use hair removal techniques as needed in conjunction with VANIQA®. (VANIQA® should be applied at least 5 minutes after hair removal.) Cosmetics or sunscreens may be applied over treated areas after cream has dried.
Ingredients
Eflornithine hydrochloride cream, 13.9% (ceteareth-20; cetearyl alcohol; dimethicone; glyceryl stearate; methylparaben; mineral oil; PEG-100 stearate; phenoxyethanol; propylparaben; stearyl alcohol; and water.
Concerns
VANIQA® (eflornithine hydrochloride) cream, 13.9% is indicated for the reduction of unwanted facial hair in women.